Since 2023, Dr. Mehmet Oz, the celebrity doctor nominated by President Trump to head the Centers for Medicare and Medicaid Services, has been a high-priced pitchman for iHerb, a California supplement retailer.
He has aggressively promoted iHerb products on social media, recommending supplements that he says will stimulate hair growth and provide smoother skin. Olive oil, which iHerb sells, he said, “might be able to actually help with Alzheimer’s.”
It turns out Dr. Oz is also a sizable investor in the supplement company, according to filings released on Wednesday by the Office of Government Ethics.
Dr. Oz pledged to sell the vast majority of his multimillion-dollar holdings, which are varied and include investments in numerous health care companies and two artificial intelligence firms.
But the fate of his iHerb holding, one of the largest in his portfolio and valued at an unspecified figure in the range of $5 million to $25 million, is unclear, according to experts who reviewed his disclosure forms.
In one filing, Dr. Oz pledged to divest his iHerb holdings “as soon as practicable but not later than 90 days after confirmation” by the Senate to the government post.